A $29m series B financing will allow 4Tech to complete a feasibility trial of its TriCinch transcatheter tricuspid valve repair system, according to the company.
The tricuspid valve, also called the right atrioventrical valve, is the valve that separates the right atrium from the right ventricle
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?